Clinical Trials Browser

Mesothelioma, Malignant

Advanced or Metastatic Solid Tumors

Advanced Solid Tumor

Locally Advanced or Metastatic Solid Tumors With PIK3CA-mutated

Advanced Solid Tumor

Solid Tumors

Advanced Solid Tumors

Advanced Solid Tumors

Advanced Solid Tumor

Solid Tumors

Solid Tumors

Locally Advanced or Metastatic Solid Tumors

Solid Tumors

Advanced Solid Tumor

Advanced/Metastatic Malignant Solid Tumors

Advanced Solid Tumor

Advanced Solid Tumor

Advanced Solid Tumors

Advanced Solid Tumors

Solid Tumors

Refractory Solid Tumors

Advanced Malignant Solid Tumors

Solid Tumor Malignancies

Solid Tumor, Adult

Solid Tumor Cancer

Advanced Solid Tumors

Advanced Solid Tumors

Advanced Solid Tumors

Advanced Solid Tumor

Solid Tumors

Solid Tumor, Adult

Advanced Solid Tumors

Solid Tumors

Advanced Solid Tumors

Advanced Solid Tumor

Advanced Solid Tumors

Advanced Solid Tumor

Advanced Cancer

Advanced Solid Tumor

NRAS Mutation

Assess the Safety and Tolerability of Various Doses and Dosing Schedules of EnteroMix in Patients With a Histologically Confirmed Solid Tumor

Solid Tumor Cancer

Advanced Malignant Solid Neoplasm

Mesothelioma, Malignant, Ovarian Neoplasms

Solid Tumor, Adult

Advanced Solid Tumors

Clinical Trials

Pembrolizumab After Radiation Therapy in Treating Patients With Pleural Malignant Mesothelioma

A Clinical Study of KK2260 in Patients With Advanced or Metastatic Solid Tumors

A Study of BG-75098 Alone and in Combination With Other Agents in Adults With Advanced Solid Tumors

GenSci145 as Monotherapy or in Combination Therapy, in Participants With PIK3CA-mutated, Locally Advanced or Metastatic Solid Tumors.

A First-in-Human Study of BG-C0979 in Adults With Advanced Solid Tumors

An Open-Label Dose-Escalation Study to Evaluate XmAb24306 as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Solid Tumors

KANDLELIT-001

A Study of BG-C477 in Participants With Advanced Solid Tumors

Study of GS-5319 in Adults With Solid Tumors

A Study to Test How Well Different Doses of BI 1831169 in Combination With an Anti-PD1 Antibody Are Tolerated in Japanese People With Different Advanced Cancers

A First-in-Human Study of BG-C0902 Alone and in Combination With Other Therapeutic Agents in Patients With Advanced Solid Tumors

A Study of SI-B036 in Patients With Locally Advanced or Metastatic Solid Tumors

A First-in-human Phase I Study to Evaluate EMB-15 in Patients With Locally Advanced or Metastatic Solid Tumors.

Phase I Study in Advanced Malignancies With 5-ALA

A Study to Find a Suitable Dose of BI 1821736 and Test Whether it Helps People With Advanced Cancer

A Study Investigating BGB-26808 Alone or in Combination With Tislelizumab in Participants With Advanced Solid Tumors

A Phase I Study to Evaluate the Safety, Tolerability, and PK of HLX43 in Advanced/Metastatic Solid Tumors

An Investigational Study of BGB-58067 As a Single Agent and in Combination With Anticancer Agents in Participants With Advanced Solid Tumors

Study of BG-T187 Alone and in Combination With Other Therapeutic Agents in Participants With Advanced Solid Tumors

Study of GS-2426 in Participants With Advanced Solid Tumors

Safety and Activity of HF50 in Patients With Advanced Solid Tumors

A Study to Test Different Doses of BI 1831169 Alone and in Combination With an Anti-PD-1 Antibody in People With Different Types of Advanced Cancer (Solid Tumors)

A Phase Ib Trial of Eribulin in Combination With Irinotecan and Temozolamide in Children With Relapsed or Refractory Solid Tumors

Trial to Assess the Safety and Antitumor Activity of GEN1057 in Malignant Solid Tumors

A Study to Investigate the Safety and Efficacy of KQB548 in Participants With Advanced Solid Malignancies

First In Human Study of CX-2051 in Advanced Solid Tumors

QLS5212 for Participants With Advanced Solid Tumors

FAK Inhibitor in Patients With Advanced Solid Tumors

KXV01 Injection in Patients With Advanced Solid Tumor (Including Osteosarcoma and Sarcoma)

A Single-Arm, Open-Label Phase Ia/Ib Clinical Trial Evaluating the Safety, Tolerability, Pharmacokinetic Profile, and Preliminary Efficacy of FS-207 in Patients With Advanced Solid Tumors With High Microsatellite Instability (MSI-H)

A Study to Evaluate PEEL-224 in Patients With Advanced Solid Tumors

Phase 1 Dose Escalation and Expansion Study of TROP2 CAR Engineered IL15-transduced Cord Blood-derived NK Cells in Patients With Advanced Solid Tumors (TROPIKANA)

First In Human Study of CX-801 in Advanced Solid Tumors

A Study to Test the Safety and Tolerability of SBO-154 in Patients With Advanced Solid Tumors.

A Study of BL-ARC002 in Patients With Locally Advanced or Metastatic Solid Tumors

A Study of SYS6051 in Subjects With Advanced Solid Tumors

Phase 1 Study of Intratumoral Administration of VAX014 With Expansion in Combination With a Checkpoint Inhibitor in Subjects With Advanced Solid Tumors

A Study of SIGX1094R in Patients With Advanced Solid Tumors

A Study of DS5361b in Participants With Advanced Solid Tumors

A Phase 1, Open-Label, Dose-Escalation Study of NEV801, Administered to Patients With Advanced Cancers

A Phase 1 Study of BHV-1530 in Advanced Solid Tumors

JH021 in Patients With Advanced Solid Tumors or EGFR-Mutant NSCLC

A First-in-human Study of RLY-8161 in Advanced NRAS-Mutant Solid Tumors

EM-I-2024

Phase I, Open-labeled, Dose-escalation, Dose-expansion Study Evaluating the Safety, Tolerance, Pharmacokinetics, and Activity of IUAb190708 in Patients With Advanced or Recurrent Solid Tumors

Cabozantinib and Pamiparib for the Treatment of Advanced of Refractory Solid Tumors

S095029 as Monotherapy and in Combination With Sym021 in Patients With Advanced Solid Tumor Malignancies Followed by an Expansion Part With Triple Combinations in Patients With Metastatic Gastric or Colorectal Cancers

SynKIR-110 for Mesothelin Expressing Ovarian Cancer, Cholangiocarcinoma or Mesothelioma

EPRAD

SKB410 for Injection in Solid Tumors